Harfst & Associates’s CONMED CNMD Stock Holding History

Harfst & Associates’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-18	Closed	-$1K	–	291
2015 Q2	$1K	Buy	+18	New	+$971	﹤0.01%	323

Other funds holding CNMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Coppersmith Capital Management New York $105M AUM 8.84% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Harfst & Associates's CNMD Position: Q3 2015 in Review

Harfst & Associates sold out of CONMED (CNMD) in Q3 2015, closing a stake of 18 shares — an estimated $1K sold.

Harfst & Associates first reported a position in CNMD in Q2 2015 and held it in 1 quarter. The position peaked at $1K in Q2 2015. 157 funds tracked by Wall St. Rank hold CNMD as of Q3 2015.

Harfst & Associates reported no remaining CONMED position as of Q3 2015 after selling out during the quarter.
Harfst & Associates sold 18 CONMED shares in Q3 2015, an estimated $1K.
Harfst & Associates first reported a position in CONMED in Q2 2015 and held it in 1 quarter.
Harfst & Associates's CONMED position peaked at $1K in Q2 2015.
157 funds tracked by Wall St. Rank held CONMED as of Q3 2015.

Based on Harfst & Associates's 13F filing for Q3 2015, filed 9 Nov 2015.